Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Nov;30(2):607–611. doi: 10.1128/iai.30.2.607-611.1980

PLC/PRF/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity.

R J Daemer, S M Feinstone, J J Alexander, J G Tully, W T London, D C Wong, R H Purcell
PMCID: PMC551353  PMID: 6160110

Abstract

The Alexander hepatoma cell line, PLC/PRF/5, was studied for evidence of hepatitis B virus markers and alpha-fetoprotein. Only hepatitis B surface antigen and alpha-fetoprotein were detected. Induction experiments with 5-iodo-2'-deoxyuridine and inoculation of chimpanzees with whole cells or tissue culture fluid did not reveal evidence of synthesis of additional hepatitis B virus markers or of production of infectious virus.

Full text

PDF
607

Images in this article

609Fig. 1
on p.609
609Fig. 2
on p.609
609Fig. 3
on p.609

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aden D. P., Fogel A., Plotkin S., Damjanov I., Knowles B. B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 1979 Dec 6;282(5739):615–616. doi: 10.1038/282615a0. [DOI] [PubMed] [Google Scholar]
  2. Alexander J. J., Bey E. M., Geddes E. W., Lecatsas G. Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J. 1976 Dec 18;50(54):2124–2128. [PubMed] [Google Scholar]
  3. Coyne V. E., Blumberg B. S., Millman I. Detection of Australia antigen in human tissue culture preparations. Proc Soc Exp Biol Med. 1971 Dec;138(3):1051–1057. doi: 10.3181/00379727-138-36048. [DOI] [PubMed] [Google Scholar]
  4. Del Giudice R. A., Robillard N. F., Carski T. R. Immunofluorescence identification of Mycoplasma on agar by use of incident illumination. J Bacteriol. 1967 Apr;93(4):1205–1209. doi: 10.1128/jb.93.4.1205-1209.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. MacNab G. M., Alexander J. J., Lecatsas G., Bey E. M., Urbanowicz J. M. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer. 1976 Nov;34(5):509–515. doi: 10.1038/bjc.1976.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Marion P. L., Salazar F. H., Alexander J. J., Robinson W. S. State of hepatitis B viral DNA in a human hepatoma cell line. J Virol. 1980 Feb;33(2):795–806. doi: 10.1128/jvi.33.2.795-806.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mathiesen L. R., Feinstone S. M., Purcell R. H., Wagner J. A. Detection of hepatitis A antigen by immunofluorescence. Infect Immun. 1977 Nov;18(2):524–530. doi: 10.1128/iai.18.2.524-530.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McGarrity G. J., Sarama J., Vanaman V. Factors influencing microbiological assay of cell-culture mycoplasma. In Vitro. 1979 Feb;15(2):73–81. doi: 10.1007/BF02618100. [DOI] [PubMed] [Google Scholar]
  9. Murphy B. L., Peterson J. M., Ebert J. W., Berquist K. R., Maynard J. E., Purcell R. H. Immunofluorescent localization of hepatitis B antigens in chimpanzee tissues. Intervirology. 1975;6(4-5):207–211. doi: 10.1159/000149475. [DOI] [PubMed] [Google Scholar]
  10. Noyes W. F. Hepatis B virus antigen development in cultured human hepatocytes. Proc Soc Exp Biol Med. 1973 Dec;144(3):845–851. doi: 10.3181/00379727-144-37695. [DOI] [PubMed] [Google Scholar]
  11. Skelly J., Copeland J. A., Howard C. R., Zuckerman A. J. Hepatitis B surface antigen produced by a human hepatoma cell line. Nature. 1979 Dec 6;282(5739):617–618. doi: 10.1038/282617a0. [DOI] [PubMed] [Google Scholar]
  12. St Jeor S., Rapp F. Cytomegalovirus replication in cells pretreated with 5-iodo-2'-deoxyuridine. J Virol. 1973 Jun;11(6):986–990. doi: 10.1128/jvi.11.6.986-990.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. St Jeor S., Rapp F. Cytomegalovirus: conversion of nonpermissive cells to a permissive state for virus replication. Science. 1973 Sep 14;181(4104):1060–1061. doi: 10.1126/science.181.4104.1060. [DOI] [PubMed] [Google Scholar]
  14. Staal S. P., Rowe W. P. Enhancement of adenovirus infection in WI-38 and AGMK cells by pretreatment of cells with 5-iododeoxyuridine. Virology. 1975 Apr;64(2):513–519. doi: 10.1016/0042-6822(75)90128-2. [DOI] [PubMed] [Google Scholar]
  15. Symes A. L., Missala K., Sourkes T. L. Iron- and riboflavin-dependent metabolism of a monamine in the rat in vivo. Science. 1971 Oct 8;174(4005):153–155. doi: 10.1126/science.174.4005.153. [DOI] [PubMed] [Google Scholar]
  16. Ulrich K., Briand P. Treatment of Mycoplasma hyorrhinis contaminated tissue cultures with a mixture of antibiotics. Acta Pathol Microbiol Scand B. 1977 Oct;85B(5):347–349. doi: 10.1111/j.1699-0463.1977.tb01986.x. [DOI] [PubMed] [Google Scholar]
  17. Zuckerman A. J., Baines P. M., Almeida J. D. Australia antigen as a marker of propagation of the serum hepatitis virus in liver cultures. Nature. 1972 Mar 10;236(5341):78–81. doi: 10.1038/236078a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Zuckerman A. J., Bird R. G. Localization of hepatitis B antigen in liver organ cultures. Br Med J. 1973 May 26;2(5864):482–482. doi: 10.1136/bmj.2.5864.482. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES